February Drug Manufacturer Call on Implementation of the IRA Medicare Provisions

Relevant to: All Drug Manufacturers

The purpose of this memorandum is to notify drug manufacturers that the Centers for Medicare & Medicaid Services (CMS), Center for Medicare hosts monthly calls on implementation of the Medicare provisions of the Inflation Reduction Act of 2022 (Public Law 117-169). The February call will be held on February 27, at 1:00 pm ET.

See the full guidance for more information.